Pregnancy after medical management of a uterine arteriovenous malformation. A case report.
BACKGROUND
The natural history of conservatively managed uterine arteriovenous malformations is largely unknown, and the risks associated with subsequent pregnancy and vaginal delivery have not been established.


METHODS
A multiparous woman with a previously reported history of uterine arteriovenous malformation was monitored throughout pregnancy and vaginal delivery. Serial ultrasound studies were performed prior to a successful induction of labor for severe preeclampsia at 34 weeks' gestation.


CONCLUSIONS
To our knowledge, this is the first report of pregnancy and vaginal delivery in a woman with a prior history of a medically managed uterine arteriovenous malformation. Noninvasive treatment of uterine arteriovenous malformations is rare, and the potential long-term risks of this approach, including pregnancy, remain uncertain.
Goldberg
R P
RP
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. r-goldberg@nwu.edu
Flynn
M K
MK
D000032:Abortion, Therapeutic / Q000009:adverse effects; D000328:Adult; D001165:Arteriovenous Malformations / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007751:Labor, Induced; D008755:Methylergonovine / Q000627:therapeutic use*; D010120:Oxytocics / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000150:complications* / Q000000981:diagnostic imaging / Q000628:therapy*; D011247:Pregnancy; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D018608:Ultrasonography, Doppler; D016216:Ultrasonography, Prenatal; D014592:Uterine Hemorrhage / Q000209:etiology; D014599:Uterus / Q000098:blood supply*
D010120:Oxytocics; D008755:Methylergonovine